Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Clinical trial NCT04216316 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04216316
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Non-Small Cell Squamous Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2021-04-14
Primary completion: 2024-03-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.